Fierce Biotech July 21, 2022
The industry group Pharmaceutical Research and Manufacturers of America (PhRMA) is hoping to break the mold, investing $10 million to launch 10 community-based trial sites in a new diversity initiative led by three medical schools.
Dubbed Equitable Breakthroughs in Medicine Development, the initiative aims to tackle systemic barriers that communities of color and historically underserved patients face when trying to access clinical trials. The goal is to build sustainable, local clinical trial infrastructure with efforts that address lack of outreach, patient mistrust and lack of available sites.
Participating schools are the Yale School of Medicine, the Morehouse School of Medicine and its Research Centers in the Minority Institutions Coordinating Center and Vanderbilt University Medical Center.
“Clearly, there...
Today's Sponsors
Today's Sponsor